Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in Depression

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

May 30, 2020

Primary Completion Date

June 6, 2022

Study Completion Date

June 6, 2022

Conditions
Major Depressive DisorderTreatment Resistant Depression
Interventions
DEVICE

repetitive transcranial magnetic stimulation

Repetitive transcranial magnetic stimulation (rTMS) is prescribed as first-line treatment for TRD patients (4). rTMS is safe, tolerable and non-invasive neurostimulation procedure where powerful magnetic pulses are transmitted through the skull into the underlying cortical cortex with the aim of electrical current induction within the neural tissue. This study administers a standard dose of rTMS treatment to the TRD patient sample consisting of high frequency deep TMS (HF-dTMS) stimulation over left dorsolateral prefrontal cortex (L-DLPFC), at the frequency of 18Hz, at 120% value of the individual's motor threshold, in 5 daily sessions per week, taking place each weekday, over the course of 6 weeks. The technology of dTMS, which will be used in this study, is an adaptation of the therapeutic intervention of rTMS with the advancement of possessing higher efficacy in targeting deeper brain regions of interest.

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03977038 - Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in Depression | Biotech Hunter | Biotech Hunter